Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis

NCT01337219 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Erempharma

Collaborators